Published in Prog Neurobiol on May 01, 1995
Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J (2001) 2.38
Modulation of an early step in the secretory machinery in hippocampal nerve terminals. Proc Natl Acad Sci U S A (1998) 1.23
Exocytosis of ATP from astrocyte progenitors modulates spontaneous Ca2+ oscillations and cell migration. Glia (2007) 1.16
Regulation of kinetic and pharmacological properties of synaptic NMDA receptors depends on presynaptic exocytosis in rat hippocampal neurones. J Physiol (1998) 0.80
Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats. Korean J Physiol Pharmacol (2015) 0.80
Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences. Exp Neurol (1997) 1.61
A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res (2009) 1.17
Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.99
Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.99
Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.98
Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97
Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. J Neurophysiol (1987) 0.96
Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res (1985) 0.91
IgA protease from Neisseria gonorrhoeae inhibits exocytosis in bovine chromaffin cells like tetanus toxin. J Biol Chem (1995) 0.90
Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.88
Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Toxicon (1986) 0.88
Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay. Mov Disord (2000) 0.88
Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action. J Neurochem (1986) 0.87
Botulinum neurotoxin - from laboratory to bedside. Neurotox Res (2006) 0.86
Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res (2003) 0.85
Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.85
Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells. Toxicon (1989) 0.82
Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution. Neurosci Lett (1989) 0.82
Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy. Neuropediatrics (2000) 0.81
Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.81
Tetanus and botulinum A toxins inhibit stimulated F-actin rearrangement in chromaffin cells. Neuroreport (1991) 0.81
Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.80
Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.80
Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin. J Neurol Neurosurg Psychiatry (1998) 0.79
Tetanus antitoxin binds to intracellular tetanus toxin in permeabilized chromaffin cells without restoring Ca2(+)-induced exocytosis. Toxicon (1990) 0.79
Results of a BoNT/A antibody study in children and adolescents after onabotulinumtoxin A (Botox®) detrusor injection. Urol Int (2011) 0.79
Uptake of antitetanus F(ab')2 fragments into eukaryotic cells. J Physiol (Paris) (1990) 0.78
Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Eur Neurol (2000) 0.78
The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans. J Neurol (2000) 0.78
Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.78
Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J Biol Chem (1994) 0.78
Kinetics of [3H]acetylcholine synthesis and release in primary cell cultures from mammalian CNS. J Neurochem (1978) 0.77
Microelectrode measurement of cell membrane potential in isolated hepatocytes attached to collagen. Biochim Biophys Acta (1986) 0.77
The translocation of botulinum A neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsin. Toxicon (1991) 0.77
Tetanus toxin and botulinum A toxin inhibit acetylcholine release from but not calcium uptake into brain tissue. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
Acid secretion of parietal cells is paralleled by a redistribution of NSF and alpha, beta-SNAPs and inhibited by tetanus toxin. Histochem Cell Biol (2000) 0.76
Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia. Neurol Clin Neurophysiol (2001) 0.76
Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport (1990) 0.76
Treatment of habitual snoring with botulinum toxin: a pilot study. Sleep Breath (2008) 0.75
Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin. Infect Immun (1992) 0.75
Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? Mov Disord (2000) 0.75
SNARE proteins and rab3A contribute to canalicular formation in parietal cells. Eur J Cell Biol (1999) 0.75
Modulation of glycine-activated membrane current by adamantane derivatives. Neuroreport (1991) 0.75
Explorations in Guatemala. Science (1884) 0.75
Action of botulinum A toxin and tetanus toxin on synaptic transmission. J Physiol (Paris) (1984) 0.75
Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures. Eur J Pharmacol (1990) 0.75